Corcept Therapeutics Inc · Brief

Next report

3 days

Nov 3 · after closeest.Q3 FY26

Expected move

±12.7%implied · straddle

70.7991.45

spot 81.12exp Nov 20ATM strike 80ATM straddle 12.15IV 79%

Oct 30 close

Expected move

—≥ implied

Q2 FY26—▲+27.29%—

quarterimplied−30%0+30%realized×

Q2 FY26—▲+27.29%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 3 report · est.

Bull2 of 3

7disclosed supplier and customer ties in SEC filingsSEC filings

431managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

8 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

29managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

CORT report session

No linked exposure.

Oct 20impliedImplied move: ±12.3% into Nov 3 earnings (Oct 20 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.